Science in Boston
@scienceinboston.com
Your complete source for life science news and events in the Greater Boston Area. Brought to you by the Science in the City program at
@stemcell.com.
@stemcell.com.
A recent study by the Laboratory for Neuro-Analysis and Imaging at @umasschan.bsky.social highlights how subcortical brain structures degenerate in #Alzheimer’s disease and frontotemporal #dementia patients.
See the work from Dr. Manojkumar Saranathan and Arit Banerjee: https://bit.ly/3NaVDn5
See the work from Dr. Manojkumar Saranathan and Arit Banerjee: https://bit.ly/3NaVDn5
January 7, 2026 at 9:48 PM
A recent study by the Laboratory for Neuro-Analysis and Imaging at @umasschan.bsky.social highlights how subcortical brain structures degenerate in #Alzheimer’s disease and frontotemporal #dementia patients.
See the work from Dr. Manojkumar Saranathan and Arit Banerjee: https://bit.ly/3NaVDn5
See the work from Dr. Manojkumar Saranathan and Arit Banerjee: https://bit.ly/3NaVDn5
New findings from Dr. Mirco Friedrich and the Zhang lab at @mit.edu showed that the liver can be transiently repurposed to restore age-diminished immune cues and improve #TCell function in aged mice: https://go.nature.com/4p6rD8Z
January 7, 2026 at 12:00 AM
New findings from Dr. Mirco Friedrich and the Zhang lab at @mit.edu showed that the liver can be transiently repurposed to restore age-diminished immune cues and improve #TCell function in aged mice: https://go.nature.com/4p6rD8Z
Researchers led by Dr. Jessica Stark (@jcstark.bsky.social) have developed a new way to stimulate the immune system to attack tumor cells, using a strategy that could make #CancerImmunotherapy work for many more patients.
📰 MIT News: https://bit.ly/3YlpCeq
📰 MIT News: https://bit.ly/3YlpCeq
January 5, 2026 at 7:50 PM
Researchers led by Dr. Jessica Stark (@jcstark.bsky.social) have developed a new way to stimulate the immune system to attack tumor cells, using a strategy that could make #CancerImmunotherapy work for many more patients.
📰 MIT News: https://bit.ly/3YlpCeq
📰 MIT News: https://bit.ly/3YlpCeq
New year, new experiments… and maybe some new habits too!
Kick off 2026 with Lab Coats and Life, the podcast that helps scientists navigate the human side of research.
If your resolutions include more balance, purpose, and curiosity, this is the perfect place to start.
🎧 https://bit.ly/4pTHNnx
Kick off 2026 with Lab Coats and Life, the podcast that helps scientists navigate the human side of research.
If your resolutions include more balance, purpose, and curiosity, this is the perfect place to start.
🎧 https://bit.ly/4pTHNnx
January 2, 2026 at 7:42 PM
New year, new experiments… and maybe some new habits too!
Kick off 2026 with Lab Coats and Life, the podcast that helps scientists navigate the human side of research.
If your resolutions include more balance, purpose, and curiosity, this is the perfect place to start.
🎧 https://bit.ly/4pTHNnx
Kick off 2026 with Lab Coats and Life, the podcast that helps scientists navigate the human side of research.
If your resolutions include more balance, purpose, and curiosity, this is the perfect place to start.
🎧 https://bit.ly/4pTHNnx
🎇 Happy New Year from Science in Boston!
Here’s to another year of discoveries that expand our understanding, collaborations that bring ideas to life, and communities that make science stronger, brighter, and more connected. 🎉
Here’s to another year of discoveries that expand our understanding, collaborations that bring ideas to life, and communities that make science stronger, brighter, and more connected. 🎉
January 1, 2026 at 5:52 PM
🎇 Happy New Year from Science in Boston!
Here’s to another year of discoveries that expand our understanding, collaborations that bring ideas to life, and communities that make science stronger, brighter, and more connected. 🎉
Here’s to another year of discoveries that expand our understanding, collaborations that bring ideas to life, and communities that make science stronger, brighter, and more connected. 🎉
🥇 Counting down to our #1 post of 2025… and here it is!
Drs. Ramnik Xavier and Christopher Smillie at the @broadinstitute.org mapped cellular location and gene activity to understand Crohn’s disease at unprecedented resolution.
https://bsky.app/profile/scienceinboston.com/post/3ltftlcyyis2z
Drs. Ramnik Xavier and Christopher Smillie at the @broadinstitute.org mapped cellular location and gene activity to understand Crohn’s disease at unprecedented resolution.
https://bsky.app/profile/scienceinboston.com/post/3ltftlcyyis2z
Dr. Ramnik Xavier and Dr. Christopher Smillie from the @broadinstitute.org analyzed individual cells from the intestinal tissue of #Crohns disease patients, measuring gene activity and mapping the cells’ location: bit.ly/4nwuf0s
📃 @natgenet.nature.com: go.nature.com/45UEWDH
📃 @natgenet.nature.com: go.nature.com/45UEWDH
Scientists discover network of cells and genes involved in Crohn’s disease complication
Spatial mapping reveals genes contributing to fibrosis, or scarring, in the gut, laying the foundation for better treatments.
bit.ly
December 31, 2025 at 4:10 PM
🥇 Counting down to our #1 post of 2025… and here it is!
Drs. Ramnik Xavier and Christopher Smillie at the @broadinstitute.org mapped cellular location and gene activity to understand Crohn’s disease at unprecedented resolution.
https://bsky.app/profile/scienceinboston.com/post/3ltftlcyyis2z
Drs. Ramnik Xavier and Christopher Smillie at the @broadinstitute.org mapped cellular location and gene activity to understand Crohn’s disease at unprecedented resolution.
https://bsky.app/profile/scienceinboston.com/post/3ltftlcyyis2z
Our #2 spot tackles global preparedness. 🌎
2025 saw the Sentinel project at @broadinstitute.org funded for the next five years to detect outbreaks in real time and stop pandemics before they start!
https://bsky.app/profile/scienceinboston.com/post/3m6i4f2bgsy2u
2025 saw the Sentinel project at @broadinstitute.org funded for the next five years to detect outbreaks in real time and stop pandemics before they start!
https://bsky.app/profile/scienceinboston.com/post/3m6i4f2bgsy2u
The John D. and Catherine T. MacArthur Foundation has awarded a $100 million, 5-year grant to the Sentinel project at @broadinstitute.org.
😷 Drs. Christian Happi & Pardis Sabeti will create a system to detect outbreaks in real time, preventing them from becoming pandemics: https://bit.ly/483My7H
😷 Drs. Christian Happi & Pardis Sabeti will create a system to detect outbreaks in real time, preventing them from becoming pandemics: https://bit.ly/483My7H
December 30, 2025 at 6:07 PM
Our #2 spot tackles global preparedness. 🌎
2025 saw the Sentinel project at @broadinstitute.org funded for the next five years to detect outbreaks in real time and stop pandemics before they start!
https://bsky.app/profile/scienceinboston.com/post/3m6i4f2bgsy2u
2025 saw the Sentinel project at @broadinstitute.org funded for the next five years to detect outbreaks in real time and stop pandemics before they start!
https://bsky.app/profile/scienceinboston.com/post/3m6i4f2bgsy2u
🧫 Our #3 post celebrates a huge step in Ebola research.
Congratulations to the Blainey and Davey labs at @mit.edu and @bumedicine.bsky.social who uncovered 998 host regulators of Ebola infection this year!
https://bsky.app/profile/scienceinboston.com/post/3lvcb3x7zuk22
Congratulations to the Blainey and Davey labs at @mit.edu and @bumedicine.bsky.social who uncovered 998 host regulators of Ebola infection this year!
https://bsky.app/profile/scienceinboston.com/post/3lvcb3x7zuk22
There are few therapeutic options for #Ebola.
The Blainey & Davey labs at @mit.edu & @bumedicine.bsky.social applied an image-based genome-wide CRISPR screen to identify 998 host regulators of Ebola infection in nearly 40 million cells and uncover new therapeutic targets: go.nature.com/40JtJCA
The Blainey & Davey labs at @mit.edu & @bumedicine.bsky.social applied an image-based genome-wide CRISPR screen to identify 998 host regulators of Ebola infection in nearly 40 million cells and uncover new therapeutic targets: go.nature.com/40JtJCA
December 29, 2025 at 2:49 PM
🧫 Our #3 post celebrates a huge step in Ebola research.
Congratulations to the Blainey and Davey labs at @mit.edu and @bumedicine.bsky.social who uncovered 998 host regulators of Ebola infection this year!
https://bsky.app/profile/scienceinboston.com/post/3lvcb3x7zuk22
Congratulations to the Blainey and Davey labs at @mit.edu and @bumedicine.bsky.social who uncovered 998 host regulators of Ebola infection this year!
https://bsky.app/profile/scienceinboston.com/post/3lvcb3x7zuk22
Coming in at #4 in our Top 5 Countdown: virus hunters assemble!
Dr. @shiraweingarten.bsky.social at @harvardmed.bsky.social launched the Laboratory of Systems Virology. We cannot wait to see what the lab accomplishes in 2026!
https://bsky.app/profile/scienceinboston.com/post/3lsuek25o5c2f
Dr. @shiraweingarten.bsky.social at @harvardmed.bsky.social launched the Laboratory of Systems Virology. We cannot wait to see what the lab accomplishes in 2026!
https://bsky.app/profile/scienceinboston.com/post/3lsuek25o5c2f
Dr. Shira Weingarten-Gabbay (@shiraweingarten.bsky.social) from @harvardmed.bsky.social is leading the new Laboratory of Systems #Virology.
Her lab uncovers the inner workings of viruses and their interaction with the immune system to prevent current and future viral diseases: bit.ly/44peaBa
Her lab uncovers the inner workings of viruses and their interaction with the immune system to prevent current and future viral diseases: bit.ly/44peaBa
December 28, 2025 at 4:18 PM
Coming in at #4 in our Top 5 Countdown: virus hunters assemble!
Dr. @shiraweingarten.bsky.social at @harvardmed.bsky.social launched the Laboratory of Systems Virology. We cannot wait to see what the lab accomplishes in 2026!
https://bsky.app/profile/scienceinboston.com/post/3lsuek25o5c2f
Dr. @shiraweingarten.bsky.social at @harvardmed.bsky.social launched the Laboratory of Systems Virology. We cannot wait to see what the lab accomplishes in 2026!
https://bsky.app/profile/scienceinboston.com/post/3lsuek25o5c2f
Starting our Top 5 Countdown with #5, we want to congratulate the Bryson Lab (@ragoninstitute.bsky.social) and their roadmap for developing better tuberculosis vaccines!
Congratulations! 💉
https://bsky.app/profile/scienceinboston.com/post/3m5wwqvoan523
Congratulations! 💉
https://bsky.app/profile/scienceinboston.com/post/3m5wwqvoan523
A new study led by the Bryson Lab at the @ragoninstitute.bsky.social lays out a practical roadmap for making better #tuberculosis vaccines.
They're using immunopeptidomics to see which TB proteins infected human immune cells display for CD4 T cells: https://bit.ly/49lmrtU
They're using immunopeptidomics to see which TB proteins infected human immune cells display for CD4 T cells: https://bit.ly/49lmrtU
December 27, 2025 at 4:10 PM
Starting our Top 5 Countdown with #5, we want to congratulate the Bryson Lab (@ragoninstitute.bsky.social) and their roadmap for developing better tuberculosis vaccines!
Congratulations! 💉
https://bsky.app/profile/scienceinboston.com/post/3m5wwqvoan523
Congratulations! 💉
https://bsky.app/profile/scienceinboston.com/post/3m5wwqvoan523
Ready for the science highlight reel of the year? 🤓 🧪
Welcome to the Science in Boston Top 5 Post Countdown, showcasing the most community-loved posts of 2025. Get ready for jaw-dropping discoveries and the people who made it all possible!
Check back tomorrow for #5...
Welcome to the Science in Boston Top 5 Post Countdown, showcasing the most community-loved posts of 2025. Get ready for jaw-dropping discoveries and the people who made it all possible!
Check back tomorrow for #5...
December 26, 2025 at 7:37 PM
Ready for the science highlight reel of the year? 🤓 🧪
Welcome to the Science in Boston Top 5 Post Countdown, showcasing the most community-loved posts of 2025. Get ready for jaw-dropping discoveries and the people who made it all possible!
Check back tomorrow for #5...
Welcome to the Science in Boston Top 5 Post Countdown, showcasing the most community-loved posts of 2025. Get ready for jaw-dropping discoveries and the people who made it all possible!
Check back tomorrow for #5...
❄️☃️ Looking for something insightful to listen to over the holidays? Explore the @immunologypodcast.com!
Whether you're traveling or unwinding at home, it’s the ideal companion for curious minds.
🎧 https://bit.ly/47nGZAG
Whether you're traveling or unwinding at home, it’s the ideal companion for curious minds.
🎧 https://bit.ly/47nGZAG
December 24, 2025 at 3:55 PM
❄️☃️ Looking for something insightful to listen to over the holidays? Explore the @immunologypodcast.com!
Whether you're traveling or unwinding at home, it’s the ideal companion for curious minds.
🎧 https://bit.ly/47nGZAG
Whether you're traveling or unwinding at home, it’s the ideal companion for curious minds.
🎧 https://bit.ly/47nGZAG
🎧 As the year winds down, it’s the perfect time to recharge your curiosity.
Explore the @stemcellpodcast.com, where experts share insights on stem cell biology, new technologies, and the future of regenerative medicine.
🎄 Add it to your holiday playlist: https://bit.ly/4pJa6VA
Explore the @stemcellpodcast.com, where experts share insights on stem cell biology, new technologies, and the future of regenerative medicine.
🎄 Add it to your holiday playlist: https://bit.ly/4pJa6VA
The Stem Cell Podcast
Join Drs. Daylon James and Arun Sharma as they discuss the latest stem cell research.
bit.ly
December 23, 2025 at 6:14 PM
🎧 As the year winds down, it’s the perfect time to recharge your curiosity.
Explore the @stemcellpodcast.com, where experts share insights on stem cell biology, new technologies, and the future of regenerative medicine.
🎄 Add it to your holiday playlist: https://bit.ly/4pJa6VA
Explore the @stemcellpodcast.com, where experts share insights on stem cell biology, new technologies, and the future of regenerative medicine.
🎄 Add it to your holiday playlist: https://bit.ly/4pJa6VA
Our website is taking a short holiday break while we recharge for 2026. But don’t worry, the science doesn’t stop!
Keep an eye on our socials over the holidays for community highlights, Top 5 countdowns, and plenty of good science stories to carry you into the new year.
See you in January! ❄️🔬
Keep an eye on our socials over the holidays for community highlights, Top 5 countdowns, and plenty of good science stories to carry you into the new year.
See you in January! ❄️🔬
December 22, 2025 at 5:05 PM
Our website is taking a short holiday break while we recharge for 2026. But don’t worry, the science doesn’t stop!
Keep an eye on our socials over the holidays for community highlights, Top 5 countdowns, and plenty of good science stories to carry you into the new year.
See you in January! ❄️🔬
Keep an eye on our socials over the holidays for community highlights, Top 5 countdowns, and plenty of good science stories to carry you into the new year.
See you in January! ❄️🔬
Dr. Sara Tolaney at @danafarber.bsky.social is the recipient of the 2025 @theaacr.bsky.social Outstanding Investigator Award for Breast Cancer Research. This award honors investigators whose work has left an impact on study of #BreastCancer.
🎉 Congratulations! https://bit.ly/3MNKvfz
🎉 Congratulations! https://bit.ly/3MNKvfz
December 19, 2025 at 6:44 PM
Dr. Sara Tolaney at @danafarber.bsky.social is the recipient of the 2025 @theaacr.bsky.social Outstanding Investigator Award for Breast Cancer Research. This award honors investigators whose work has left an impact on study of #BreastCancer.
🎉 Congratulations! https://bit.ly/3MNKvfz
🎉 Congratulations! https://bit.ly/3MNKvfz
Scientists at @harvardmed.bsky.social uncovered new genetic details of #FriedreichsAtaxia, a devastating neurodegenerative disorder that does not yet have a cure.
Drs. Vamsi Mootha and Joshua Meisel described a genetic modifier that enables cells to survive without frataxin: https://bit.ly/4pH0NWj
Drs. Vamsi Mootha and Joshua Meisel described a genetic modifier that enables cells to survive without frataxin: https://bit.ly/4pH0NWj
December 18, 2025 at 5:58 PM
Scientists at @harvardmed.bsky.social uncovered new genetic details of #FriedreichsAtaxia, a devastating neurodegenerative disorder that does not yet have a cure.
Drs. Vamsi Mootha and Joshua Meisel described a genetic modifier that enables cells to survive without frataxin: https://bit.ly/4pH0NWj
Drs. Vamsi Mootha and Joshua Meisel described a genetic modifier that enables cells to survive without frataxin: https://bit.ly/4pH0NWj
Dr. Xueyang Dong, a postdoctoral researcher in the Nagashima lab at @harvardmcb.bsky.social , has been selected for a prestigious Cancer Research Institute Postdoctoral Fellowship.
He will be working to uncover how the immune system recognizes #GutBacteria. Congratulations! https://bit.ly/48VJfyl
He will be working to uncover how the immune system recognizes #GutBacteria. Congratulations! https://bit.ly/48VJfyl
December 17, 2025 at 7:39 PM
Dr. Xueyang Dong, a postdoctoral researcher in the Nagashima lab at @harvardmcb.bsky.social , has been selected for a prestigious Cancer Research Institute Postdoctoral Fellowship.
He will be working to uncover how the immune system recognizes #GutBacteria. Congratulations! https://bit.ly/48VJfyl
He will be working to uncover how the immune system recognizes #GutBacteria. Congratulations! https://bit.ly/48VJfyl
Reposted by Science in Boston
Our most popular interview of 2025. @robertwaldinger.bsky.social leads the Harvard Study on Adult Development, one of the longest-running scientific investigations into human wellbeing. Earlier this year, he sat down with us to discuss the secret to happiness: hvrdct.me/2a2c97
Staying Zen in Tumultuous Times
hvrdct.me
December 17, 2025 at 4:20 PM
Our most popular interview of 2025. @robertwaldinger.bsky.social leads the Harvard Study on Adult Development, one of the longest-running scientific investigations into human wellbeing. Earlier this year, he sat down with us to discuss the secret to happiness: hvrdct.me/2a2c97
A personalized biomaterial #CancerVaccine just passed its first-in-human test!
Started by Drs. Stephen Hodi & David Mooney's labs at the @wyssinstitute.bsky.social in 2013, the trial showed that the system can be consistently fabricated and applied to patients: https://bit.ly/3KPfHe0
Started by Drs. Stephen Hodi & David Mooney's labs at the @wyssinstitute.bsky.social in 2013, the trial showed that the system can be consistently fabricated and applied to patients: https://bit.ly/3KPfHe0
December 16, 2025 at 11:57 PM
A personalized biomaterial #CancerVaccine just passed its first-in-human test!
Started by Drs. Stephen Hodi & David Mooney's labs at the @wyssinstitute.bsky.social in 2013, the trial showed that the system can be consistently fabricated and applied to patients: https://bit.ly/3KPfHe0
Started by Drs. Stephen Hodi & David Mooney's labs at the @wyssinstitute.bsky.social in 2013, the trial showed that the system can be consistently fabricated and applied to patients: https://bit.ly/3KPfHe0
Drs. Lina Marcela Carmona and Nils Grotehans from @umasschan.bsky.social has received awards from the American Federation for Aging Research and the Glenn Foundation.
Congratulations to both researchers! https://bit.ly/3MuZoDA
Congratulations to both researchers! https://bit.ly/3MuZoDA
December 15, 2025 at 3:07 PM
Drs. Lina Marcela Carmona and Nils Grotehans from @umasschan.bsky.social has received awards from the American Federation for Aging Research and the Glenn Foundation.
Congratulations to both researchers! https://bit.ly/3MuZoDA
Congratulations to both researchers! https://bit.ly/3MuZoDA
We're having a great time at the Boston ISSCR PSC-Derived Therapies Symposium, but the fun isn't over! 🤩
Remember to stop by booth #18 for a chance to win a prize and chat with our team!
Remember to stop by booth #18 for a chance to win a prize and chat with our team!
December 12, 2025 at 12:45 PM
We're having a great time at the Boston ISSCR PSC-Derived Therapies Symposium, but the fun isn't over! 🤩
Remember to stop by booth #18 for a chance to win a prize and chat with our team!
Remember to stop by booth #18 for a chance to win a prize and chat with our team!
Thanks to everyone who attended our Innovation Showcase by Dr. Andrew Gaffney and Dr. Janet Rothberg from CCRM!
👋 See you tomorrow for Day 2 of the Boston ISSCR PSC-Derived Therapies Symposium!
👋 See you tomorrow for Day 2 of the Boston ISSCR PSC-Derived Therapies Symposium!
December 12, 2025 at 12:55 AM
Thanks to everyone who attended our Innovation Showcase by Dr. Andrew Gaffney and Dr. Janet Rothberg from CCRM!
👋 See you tomorrow for Day 2 of the Boston ISSCR PSC-Derived Therapies Symposium!
👋 See you tomorrow for Day 2 of the Boston ISSCR PSC-Derived Therapies Symposium!
The ISSCR PSC-Derived Therapies Symposium is buzzing already! 🤩 What's in store for today?
Starting with an Innovation Showcase at 2 pm, check out Dr. Andrew Gaffney's talk!
Come check out Kimberly Snyder's work:
📍Poster #117 at Poster Session 1 ODD
📍Poster #158 at Poster Session 2 EVEN
Starting with an Innovation Showcase at 2 pm, check out Dr. Andrew Gaffney's talk!
Come check out Kimberly Snyder's work:
📍Poster #117 at Poster Session 1 ODD
📍Poster #158 at Poster Session 2 EVEN
December 11, 2025 at 6:05 PM
The ISSCR PSC-Derived Therapies Symposium is buzzing already! 🤩 What's in store for today?
Starting with an Innovation Showcase at 2 pm, check out Dr. Andrew Gaffney's talk!
Come check out Kimberly Snyder's work:
📍Poster #117 at Poster Session 1 ODD
📍Poster #158 at Poster Session 2 EVEN
Starting with an Innovation Showcase at 2 pm, check out Dr. Andrew Gaffney's talk!
Come check out Kimberly Snyder's work:
📍Poster #117 at Poster Session 1 ODD
📍Poster #158 at Poster Session 2 EVEN
Glioblastoma is the most common form of brain cancer in adults, and its usually quick and fatal.
A study from the @mitkochinstitute.bsky.social profiling antigens presented on immune and tumor cells in co-culture points to new strategies for attacking #glioblastoma: https://bit.ly/4aGcO9E
A study from the @mitkochinstitute.bsky.social profiling antigens presented on immune and tumor cells in co-culture points to new strategies for attacking #glioblastoma: https://bit.ly/4aGcO9E
December 10, 2025 at 10:11 PM
Glioblastoma is the most common form of brain cancer in adults, and its usually quick and fatal.
A study from the @mitkochinstitute.bsky.social profiling antigens presented on immune and tumor cells in co-culture points to new strategies for attacking #glioblastoma: https://bit.ly/4aGcO9E
A study from the @mitkochinstitute.bsky.social profiling antigens presented on immune and tumor cells in co-culture points to new strategies for attacking #glioblastoma: https://bit.ly/4aGcO9E
Reposted by Science in Boston
Online & self-paced course designed for healthcare professionals, researchers, & medical students who are interested in learning more about genomic medicine. Free for Harvard affiliates & open to others for a fee: hvrdct.me/19a7ba
December 10, 2025 at 6:13 PM
Online & self-paced course designed for healthcare professionals, researchers, & medical students who are interested in learning more about genomic medicine. Free for Harvard affiliates & open to others for a fee: hvrdct.me/19a7ba